SBC

+ Watchlist + Portfolio

SBC Medical Group Holdings Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.87
52-Week Range: $2.78 – $5.07
Market Cap: $378.48M
P/E (TTM): 7.67
EPS (TTM): 0.48
Dividend Yield: —

Advanced Metrics

Price/Book: 1.48
PEG Ratio: 1.62
Return on Equity: 18.91%
Return on Assets: 11.32%
Gross Margin: 71.85%
Operating Margin: 38.55%
Profit Margin: 27.99%
Current Ratio: 3.31
Debt/Equity: 0.17
Total Debt: $48.23M
Free Cash Flow: $63.19M
Revenue Growth: 13.40%
Earnings Growth: 338.90%
Enterprise Value: $258.17M

SBC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$174.16M	$193.54M	$205.42M	$173.61M
Cost of Revenue	$59.33M	$56.24M	$49.37M	$46.32M
Gross Profit	$114.83M	$137.30M	$156.05M	$127.28M
Selling, General & Admin	$93.48M	$66.23M	$70.69M	$59.80M
Operating Expenses	$93.48M	$66.23M	$70.69M	$59.80M
Operating Income	$21.35M	$71.07M	$85.36M	$67.49M
EBITDA	$29.64M	$85.87M	$77.28M	$84.91M
Pretax Income	$23.68M	$73.58M	$73.46M	$82.07M
Income Tax	$18.12M	$35.02M	$26.77M	$31.02M
Net Income	$6.32M	$39.37M	$46.61M	$50.99M
Diluted EPS	0.06	0.39	0.48	0.50
Diluted Shares	100.74M	100.74M	96.56M	103.00M

SBC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$51.74M	$103.02M	$125.04M	$163.77M
Receivables	$43.65M	$53.13M	$48.19M	$53.10M
Inventory	$1.35M	$3.09M	$1.49M	$2.79M
Current Assets	$112.95M	$165.91M	$184.45M	$231.22M
Total Assets	$225.48M	$258.81M	$266.08M	$380.45M
Current Liabilities	$101.25M	$92.45M	$61.19M	$61.12M
Long-Term Debt	$5.53M	$13.01M	$6.51M	$33.73M
Total Debt	$16.13M	$22.87M	$12.21M	$51.64M
Total Liabilities	$117.63M	$115.00M	$71.06M	$117.14M
Retained Earnings	$103.48M	$142.85M	$189.46M	$240.45M
Shareholders' Equity	$105.25M	$142.16M	$195.11M	$248.28M
Working Capital	$11.70M	$73.45M	$123.26M	$170.10M

SBC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$47.37K	$50.67M	$20.58M	$24.67M
Capital Expenditure	-$24.95M	-$11.21M	-$3.41M	-$2.70M
Free Cash Flow	-$24.99M	$39.46M	$17.17M	$21.96M
Depreciation & Amortisation	$5.93M	$12.25M	$3.80M	$2.68M
Stock-Based Compensation	—	$0.00	$13.02M	$0.00
Investing Cash Flow	-$32.65M	$1.79M	-$10.10M	-$20.97M
Financing Cash Flow	-$7.98M	$6.14M	$22.97M	$38.29M
Share Repurchases	—	—	$0.00	-$5.00M
Net Change in Cash	-$40.68M	$58.60M	$33.45M	$41.99M

SBC Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$47.33M	$43.36M	$43.35M	$39.57M	$43.06M
Cost of Revenue	$9.60M	$13.35M	$12.74M	$10.64M	$12.71M
Gross Profit	$37.73M	$30.01M	$30.61M	$28.93M	$30.35M
Selling, General & Admin	$12.82M	$14.39M	$13.95M	$18.63M	$12.23M
Operating Expenses	$13.53M	$15.46M	$14.73M	$16.08M	$12.63M
Operating Income	$24.20M	$14.55M	$15.88M	$12.85M	$17.72M
EBITDA	$32.09M	$14.23M	$19.30M	$19.30M	$19.64M
Pretax Income	$31.45M	$13.54M	$18.51M	$18.57M	$18.86M
Income Tax	$9.96M	$11.10M	$5.67M	$4.29M	$7.53M
Net Income	$21.50M	$2.46M	$12.82M	$14.20M	$11.31M
Diluted EPS	0.21	0.02	0.12	0.14	0.11
Diluted Shares	103.28M	103.51M	102.64M	102.58M	102.58M

SBC Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$132.06M	$152.74M	$127.43M	$163.77M	$167.31M
Receivables	$67.02M	$73.20M	$83.83M	$53.10M	$58.36M
Inventory	$1.69M	$1.71M	$1.68M	$2.79M	$2.32M
Current Assets	$215.10M	$241.34M	$227.20M	$231.22M	$238.78M
Total Assets	$284.61M	$315.30M	$321.36M	$380.45M	$388.02M
Current Liabilities	$48.47M	$60.68M	$44.58M	$61.12M	$62.57M
Long-Term Debt	$6.81M	$7.03M	$18.08M	$33.73M	$31.45M
Total Debt	$14.10M	$15.53M	$28.15M	$51.64M	$51.90M
Total Liabilities	$58.28M	$70.65M	$73.30M	$117.14M	$117.64M
Retained Earnings	$210.97M	$213.42M	$226.25M	$240.45M	$251.76M
Shareholders' Equity	$226.45M	$244.59M	$247.99M	$248.28M	$255.34M
Working Capital	$166.63M	$180.66M	$182.62M	$170.10M	$176.21M

SBC Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$1.93M	-$8.34M	-$20.88M	$51.96M	$9.23M
Capital Expenditure	-$754.98K	-$510.80K	-$176.27K	-$1.26M	-$548.87K
Free Cash Flow	$1.17M	-$8.85M	-$21.06M	$50.70M	$8.68M
Depreciation & Amortisation	$628.30K	$636.10K	$746.21K	$673.68K	$670.43K
Stock-Based Compensation	—	—	—	$0.00	—
Investing Cash Flow	-$978.81K	$16.38M	-$12.16M	-$24.21M	-$528.02K
Financing Cash Flow	-$280.38K	$7.18M	$11.57M	$19.82M	-$1.84M
Share Repurchases	—	—	-$2.58M	$0.00	—
Net Change in Cash	$669.43K	$15.22M	-$21.47M	$47.58M	$6.86M

Market Snapshot

About

SBC Medical Group Holdings Inc. is a medical aesthetics services provider operating primarily in Asia. The company offers non-invasive and minimally invasive aesthetic treatments through its network of clinics. SBC Medical Group focuses on skincare, body contouring, and other cosmetic procedures for health-conscious consumers.